


Incyte to Report 2010 Financial Results and Provide 2011 Key Objectives and Financial Guidance on February 10
WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its fourth quarter/year-end 2010 financial results conference call for 8:30 a.m. ET on Thursday, February 10, 2011. The schedules for the press release and conference call are as follows:
-- Q4 & YE 2010 Press Release: | February 10, 2011 at 7:00 a.m. ET | |||||
-- Q4 & YE 2010 Conference Call: | February 10, 2011 at 8:30 a.m. ET | |||||
-- Domestic Dial In Number: | 877-407-8037 | |||||
-- International Dial In Number: | 201-689-8037 | |||||
-- Conference ID # | 366256 | |||||
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 366256.
The conference call will also be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].